• First book dedicated to this disease, previously thought to be incurable, but with the advent of new drugs, now amenable to management and a much improved prognosis for patients
• From the PAH Association, the leading experts in field
• Incorporates the latest AACP management guidelines
• Includes evidence-based treatment algorithms based on the recently updated ACCP Guidelines for Medical Treatment
• Aimed at specialists in pulmonology and cardiovascular disease, this volume provides the clinician with the most up to date information on the effective management of PAH

From the Back Cover
Pulmonary hypertension is frequently misdiagnosed and has often progressed to a late stage by the time it is accurately diagnosed. It has therefore long been considered untreatable and incurable with an overall very poor survival rate. However, new treatments are now available which have significantly improved prognosis. Recent data demonstrate survival is continuing to improve, with patients living for fifteen to twenty years or longer after diagnosis with an overall good quality of life.In this work, each chapter will discuss therapeutic options with reference to the pre clinical studies which provided the rationale for their clinical development. The book will also include evidence-based treatment algorithms based on the 2007 update of the ACCP Guidelines for Medical Treatment of Pulmonary Hypertension.

Aimed at specialists in pulmonary and cardiovascular disease, this volume provides the clinician with the most up to date information on the effective management of pulmonary hypertension.